FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Midori Shima

Research Profile

Chemicals & Drugs

Disorders

Hemophilia A

Procedures

Concepts & Ideas

Phenomena

Physiology

Blood Coagulation

Co-author Network

Publications

TOP 3
K Yada; Keiji Nogami; K Ogiwara; Midori Shima
Activated prothrombin complex concentrate (APCC)-mediated activation of factor (F)VIII in mixtures of FVIII and APCC enhances hemostatic effectiveness.
Tamaki Hayashi; Yoshihiro Hayata; Tomoko Matsumoto; Kenichi Ogiwara; Yoshihiko Sakurai; Yukihiro Takahashi; Shigeki Taniguchi; Koji Yada; Yoshiro Yoshikawa; Hiroyuki Yoshizawa; Kazuyoshi Fukuda; Midori Shima
Correlations between global clotting function tests, duration of operation, and postoperative chest tube drainage in pediatric cardiac surgery.
Kohei Tatsumi; Kazuo Ohashi; Sanae Taminishi; Yoshihiko Sakurai; Kenichi Ogiwara; Akira Yoshioka; Teruo Okano; Midori Shima
Regulation of coagulation factors during liver regeneration in mice: mechanism of factor VIII elevation in plasma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Midori Shima (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: K Yada; Keiji Nogami; K Ogiwara; Midori Shima
Activated prothrombin complex concentrate (APCC)-mediated activation of factor (F)VIII in mixtures of FVIII and APCC enhances hemostatic effectiveness.
Journal of thrombosis and haemostasis : JTH 2013;11(5):902-10.
2011: Tamaki Hayashi; Yoshihiro Hayata; Tomoko Matsumoto; Kenichi Ogiwara; Yoshihiko Sakurai; Yukihiro Takahashi; Shigeki Taniguchi; Koji Yada; Yoshiro Yoshikawa; Hiroyuki Yoshizawa; Kazuyoshi Fukuda; Midori Shima
Correlations between global clotting function tests, duration of operation, and postoperative chest tube drainage in pediatric cardiac surgery.
Paediatric anaesthesia 2011;21(8):865-71.
2011: Kohei Tatsumi; Kazuo Ohashi; Sanae Taminishi; Yoshihiko Sakurai; Kenichi Ogiwara; Akira Yoshioka; Teruo Okano; Midori Shima
Regulation of coagulation factors during liver regeneration in mice: mechanism of factor VIII elevation in plasma.
Thrombosis research 2011;128(1):54-61.
2010: T Soeda; Keiji Nogami; Tomoko Matsumoto; K Ogiwara; Midori Shima
Mechanisms of factor VIIa-catalyzed activation of factor VIII.
Journal of thrombosis and haemostasis : JTH 2010;8(11):2494-503.
2010: Kenichi Ogiwara; Keiji Nogami; Katsumi Nishiya; Midori Shima
Plasmin-induced procoagulant effects in the blood coagulation: a crucial role of coagulation factors V and VIII.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2010;21(6):568-76.
2010: Masahiro Takeyama; Keiji Nogami; Tomoko Matsumoto; Tetsuhiro Soeda; Tsukasa Suzuki; Kunihiro Hattori; Midori Shima
Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity.
Thrombosis and haemostasis 2010;103(1):94-102.
2009: Tomoko Matsumoto; Keiji Nogami; Kenichi Ogiwara; Midori Shima
A modified thrombin generation test for investigating very low levels of factor VIII activity in hemophilia A.
International journal of hematology 2009;90(5):576-82.
2009: Shogo Kasuda; Minori Nishiguchi; Shie Yoshida; Nao Ohtsu; Nobuyuki Adachi; Yoshihiko Sakurai; Midori Shima; Motonari Takahashi; Katsuhiko Hatake; Hiroshi Kinoshita
Enhancement effect of ethanol on lipopolysaccharide-induced procoagulant status in human umbilical endothelial cells.
Soudní lékarství / casopis Sekce soudního lékarstvi Cs. lékarské spolecnosti J. Ev. Purkyne 2009;54(4):44-8.
2009: Masahiro Takeyama; Keiji Nogami; Evgueni L Saenko; Katsumi Nishiya; Kenichi Ogiwara; Midori Shima
Identification of a protein S-interactive site within the A2 domain of the factor VIII heavy chain.
Thrombosis and haemostasis 2009;102(4):645-55.
2009: Masahiro Takeyama; Keiji Nogami; Masahiro Okuda; Midori Shima
von Willebrand factor protects the Ca2+-dependent structure of the factor VIII light chain.
British journal of haematology 2009;146(5):531-7.
2009: Shogo Kasuda; Risa Kudo; Yoshifumi Morimura; Kohei Tatsumi; Yoshihiko Sakurai; Midori Shima; Katsuhiko Hatake
von Willebrand factor in cadaveric urine for forensic investigation.
Legal medicine (Tokyo, Japan) 2009;11(5):245-7.
2009: Keiji Nogami; Katsumi Nishiya; Evgueni L Saenko; Masahiro Takeyama; Kenichi Ogiwara; Akira Yoshioka; Midori Shima
Identification of plasmin-interactive sites in the light chain of factor VIII responsible for proteolytic cleavage at Lys36.
The Journal of biological chemistry 2009;284(11):6934-45.
2009: Tetsuhiro Soeda; Keiji Nogami; Katsumi Nishiya; Masahiro Takeyama; Kenichi Ogiwara; Yoichi Sakata; Akira Yoshioka; Midori Shima
The factor VIIIa C2 domain (residues 2228-2240) interacts with the factor IXa Gla domain in the factor Xase complex.
The Journal of biological chemistry 2009;284(6):3379-88.
2009: Tomohiro Takeda; Yoshihiko Sakurai; Kohei Tatsumi; Junko Kato; Shogo Kasuda; Akira Yoshioka; Midori Shima
Elevation of B cell-activating factor belonging to the tumour necrosis factor [corrected] family (BAFF) in haemophilia A patients with inhibitor.
Thrombosis and haemostasis 2009;101(2):408-10.
2008: Masahiro Takeyama; Keiji Nogami; Evgueni L Saenko; Tetsuhiro Soeda; Katsumi Nishiya; Kenichi Ogiwara; Akira Yoshioka; Midori Shima
Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa.
British journal of haematology 2008;143(3):409-20.
2008: Kohei Tatsumi; Kazuo Ohashi; Sanae Taminishi; Teruo Okano; Akira Yoshioka; Midori Shima
Reference gene selection for real-time RT-PCR in regenerating mouse livers.
Biochemical and biophysical research communications 2008;374(1):106-10.
2008: Masahiro Takeyama; Keiji Nogami; Masahiro Okuda; Yoshihiko Sakurai; Tomoko Matsumoto; Ichiro Tanaka; Akira Yoshioka; Midori Shima
Selective factor VIII and V inactivation by iminodiacetate ion exchange resin through metal ion adsorption.
British journal of haematology 2008;142(6):962-70.
2008: S Kasuda; A Kubo; Yoshihiko Sakurai; S Irion; K Ohashi; K Tatsumi; Y Nakajima; Y Saito; K Hatake; Steven W Pipe; Midori Shima; Akira Yoshioka
Establishment of embryonic stem cells secreting human factor VIII for cell-based treatment of hemophilia A.
Journal of thrombosis and haemostasis : JTH 2008;6(8):1352-9.
2008: Kohei Tatsumi; Kazuo Ohashi; Midori Shima; Yoshiyuki Nakajima; Teruo Okano; Akira Yoshioka
Therapeutic effects of hepatocyte transplantation on hemophilia B.
Transplantation 2008;86(1):167-70.
2008: Midori Shima; Tomoko Matsumoto; K Ogiwara
New assays for monitoring haemophilia treatment.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14 Suppl 3():83-92.
2008: Kohei Tatsumi; Kazuo Ohashi; Miho Kataoka; Chise Tateno; Masaru Shibata; Hiroyuki Naka; Midori Shima; Michiyoshi Hisanaga; Hiromichi Kanehiro; Teruo Okano; Katsutoshi Yoshizato; Yoshiyuki Nakajima; Akira Yoshioka
Successful in vivo propagation of factor IX-producing hepatocytes in mice: potential for cell-based therapy in haemophilia B.
Thrombosis and haemostasis 2008;99(5):883-91.
2008: Keiji Nogami; Katsumi Nishiya; Evgueni L Saenko; Masahiro Takeyama; Ichiro Tanaka; Akira Yoshioka; Midori Shima
Identification of a plasmin-interactive site within the A2 domain of the factor VIII heavy chain.
Biochimica et biophysica acta 2008;1784(5):753-63.
2008: Keiji Nogami; Evgueni L Saenko; Masahiro Takeyama; John C Giddings; Akira Yoshioka; Midori Shima
Identification of a thrombin-interactive site within the FVIII A2 domain that is responsible for the cleavage at Arg372.
British journal of haematology 2008;140(4):433-43.
2007: Takafumi Sakakibara; Yukihiro Takahashi; Kazuyoshi Fukuda; Tomomi Inoue; Tomoko Kurosawa; Toshiya Nishikubo; Midori Shima; Toshiaki Taoka; Noriko Aida; Seiichi Tsujino; Naomi Kanazawa; Akira Yoshioka
A case of infantile Alexander disease diagnosed by magnetic resonance imaging and genetic analysis.
Brain & development 2007;29(8):525-8.
2007: Masahiro Takeyama; Shogo Kasuda; Yoshihiko Sakurai; Midori Shima; Tomohiro Takeda; Shoko Omura; Hiroyuki Naka; Akira Yoshioka
Factor VIII-mediated global hemostasis in the absence of von Willebrand factor.
International journal of hematology 2007;85(5):397-402.
2007: Keiji Nogami; Midori Shima; John C Giddings; Masahiro Takeyama; Ichiro Tanaka; Akira Yoshioka
Relationship between the binding sites for von Willebrand factor, phospholipid, and human factor VIII C2 inhibitor alloantibodies within the factor VIII C2 domain.
International journal of hematology 2007;85(4):317-22.
2007: Keiji Nogami; Midori Shima; Tomoko Matsumoto; Katsumi Nishiya; Ichiro Tanaka; Akira Yoshioka
Mechanisms of plasmin-catalyzed inactivation of factor VIII: a crucial role for proteolytic cleavage at Arg336 responsible for plasmin-catalyzed factor VIII inactivation.
The Journal of biological chemistry 2007;282(8):5287-95.
2007: Yoshihiko Sakurai; Hiroyuki Sugimoto; Koichi Yoshida; Ichiro Tanaka; Midori Shima; Yasuhito Tanaka; Maiko Takeda; Akitaka Nonomura; Akira Yoshioka
Superficial fibromatosis mimicking subcutaneous hematoma: an unusual and difficult diagnosis in a patient with mild hemophilia A.
International journal of hematology 2007;85(1):1-4.
2007: Masahiro Takeyama; Yoshihiko Sakurai; Midori Shima; Tomoko Matsumoto; Keiji Nogami; Ichiro Tanaka; Tomohiro Takeda; John C Giddings; Akira Yoshioka
Heparin-induced inhibitory effects of a prothrombin complex concentrate on global tests of haemostasis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007;18(1):1-7.
2006: Shogo Kasuda; Yoshihiko Sakurai; Midori Shima; Yoshifumi Morimura; Risa Kudo; Tomohiro Takeda; Akiko Ishitani; Akira Yoshioka; Katsuhiko Hatake
Inhibition of PAR4 signaling mediates ethanol-induced attenuation of platelet function in vitro.
Alcoholism, clinical and experimental research 2006;30(9):1608-14.
2006: Hiroshi Suzuki; Midori Shima; Keiji Nogami; Yoshihiko Sakurai; Katsumi Nishiya; Evgueni L Saenko; Ichiro Tanaka; Akira Yoshioka
Factor V C2 domain contains a major thrombin-binding site responsible for thrombin-catalyzed factor V activation.
Journal of thrombosis and haemostasis : JTH 2006;4(6):1354-60.
2006: Yoshihiko Sakurai; Midori Shima; Yuichirou Imai; Shoko Omura; Tadaaki Kirita; Akira Yoshioka
Successful use of recombinant factor VIII devoid of von Willebrand factor during multiple teeth extractions in a patient with type 3 von Willebrand disease.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2006;17(2):151-4.
2006: Midori Shima
Characterization of factor VIII inhibitors.
International journal of hematology 2006;83(2):109-18.
2006: Tomoko Matsumoto; Midori Shima; Masahiro Takeyama; Koichi Yoshida; Ichiro Tanaka; Yoshihiko Sakurai; Alan R Giles; Akira Yoshioka
The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay.
Journal of thrombosis and haemostasis : JTH 2006;4(2):377-84.
2006: T Inoue; Midori Shima; Masahiro Takeyama; Tomoko Matsumoto; Katsumi Nishiya; Ichiro Tanaka; Yoshihiko Sakurai; John C Giddings; Akira Yoshioka
Higher recovery of factor VIII (FVIII) with intermediate FVIII/von Willebrand factor concentrate than with recombinant FVIII in a haemophilia A patient with an inhibitor.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12(1):110-3.
2004: T Hayashi; Ichiro Tanaka; Midori Shima; Koichi Yoshida; Kazuyoshi Fukuda; Yoshihiko Sakurai; Tomoko Matsumoto; John C Giddings; Akira Yoshioka
Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor.
Haemophilia : the official journal of the World Federation of Hemophilia 2004;10(4):397-400.
2004: Shogo Kasuda; Ichiro Tanaka; Midori Shima; Tomoko Matsumoto; Yoshihiko Sakurai; Katsumi Nishiya; Alan R Giles; Akira Yoshioka
Effectiveness of factor VIII infusions in haemophilia A patients with high responding inhibitors.
Haemophilia : the official journal of the World Federation of Hemophilia 2004;10(4):341-6.
2004: Yoshihiko Sakurai; Midori Shima; Ichiro Tanaka; Kazuyoshi Fukuda; Koichi Yoshida; Akira Yoshioka
Association of anti-idiotypic antibodies with immune tolerance induction for the treatment of hemophilia A with inhibitors.
Haematologica 2004;89(6):696-703.
2004: Kazuyoshi Fukuda; Hiroyuki Naka; Shogo Morichika; Masaru Shibata; Ichiro Tanaka; Midori Shima; Akira Yoshioka
Inversions of the factor VIII gene in Japanese patients with severe hemophilia A.
International journal of hematology 2004;79(3):303-6.
2004: Yukiko Hayashi; Midori Shima; Hiromichi Kanehiro; Yousuke Nakajima; Natsuko Daikoku; Masanori Higuchi; Sachiko Miyagawa; Seiki Kamisue; Kazuyoshi Fukuda; Ichiro Tanaka; John C Giddings; Akira Yoshioka
Ecthyma gangrenosum combined with multiple perforations of the small intestine associated with Pseudomonas aeruginosa.
Pediatrics international : official journal of the Japan Pediatric Society 2004;46(1):104-8.
2004: Yoshihiko Sakurai; Midori Shima; John C Giddings; Masahiro Takeyama; Shogo Kasuda; Keiji Nogami; Katsumi Nishiya; Akira Yoshioka
A critical role for thrombin in platelet aggregation under high shear stress.
Thrombosis research 2004;113(5):311-8.
2004: Midori Shima
Understanding the hemostatic effects of recombinant factor VIIa by clot wave form analysis.
Seminars in hematology 2004;41(1 Suppl 1):125-31.
2003: Yoshihiko Sakurai; Midori Shima; Tomoko Matsumoto; Hideo Takatsuka; Katsumi Nishiya; Shogo Kasuda; Yoshihiro Fujimura; Akira Yoshioka
Anticoagulant activity of M-LAO, L-amino acid oxidase purified from Agkistrodon halys blomhoffii, through selective inhibition of factor IX.
Biochimica et biophysica acta 2003;1649(1):51-7.
2003: M Shibata; Midori Shima; H Misu; Y Okimoto; John C Giddings; Akira Yoshioka
Management of haemophilia B inhibitor patients with anaphylactic reactions to FIX concentrates.
Haemophilia : the official journal of the World Federation of Hemophilia 2003;9(3):269-71.
2002: Masayuki Nishiguchi; Midori Shima; Yukihiro Takahashi; Hiroaki Matsuoka; Shinichi Fujimoto; Kouji Taira; Akira Yoshioka
[A boy with occipital lobe epilepsy showing prolonged QTc in the ictal ECG].
No to hattatsu. Brain and development 2002;34(6):523-7.
2002: Keiji Nogami; Midori Shima; Katsumi Nishiya; Kazuya Hosokawa; Evgueni L Saenko; Yoshihiko Sakurai; Masaru Shibata; Hiroshi Suzuki; Ichiro Tanaka; Akira Yoshioka
A novel mechanism of factor VIII protection by von Willebrand factor from activated protein C-catalyzed inactivation.
Blood 2002;99(11):3993-8.
2002: Keiji Nogami; Midori Shima; Katsumi Nishiya; Yoshihiko Sakurai; Ichiro Tanaka; John C Giddings; Evgueni L Saenko; Akira Yoshioka
Human factor VIII inhibitor alloantibodies with a C2 epitope inhibit factor Xa-catalyzed factor VIII activation: a new anti-factor VIII inhibitory mechanism.
Thrombosis and haemostasis 2002;87(3):459-65.
2002: Midori Shima; Tomoko Matsumoto; Kazuyoshi Fukuda; Youko Kubota; Ichiro Tanaka; Katsumi Nishiya; Alan R Giles; Akira Yoshioka
The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C).
Thrombosis and haemostasis 2002;87(3):436-41.
2002: Keiji Nogami; Midori Shima; Katsumi Nishiya; Kazuya Hosokawa; Evgueni L Saenko; John C Giddings; Ichiro Tanaka; Akira Yoshioka
Anticoagulant effects of a synthetic peptide containing residues Thr-2253-Gln-2270 within factor VIII C2 domain that selectively inhibits factor Xa-catalysed factor VIII activation.
British journal of haematology 2002;116(4):868-74.
2001: Tomoko Matsumoto; Midori Shima; Kazuyoshi Fukuda; Keiji Nogami; John C Giddings; T Murakami; Ichiro Tanaka; Akira Yoshioka
Immunological characterization of factor VIII autoantibodies in patients with acquired hemophilia A in the presence or absence of underlying disease.
Thrombosis research 2001;104(6):381-8.
2001: Akira Yoshioka; Midori Shima; K Fukutake; J Takamatsu; A Shirahata
Safety and efficacy of a new recombinant FVIII formulated with sucrose (rFVIII-FS) in patients with haemophilia A: a long-term, multicentre clinical study in Japan.
Haemophilia : the official journal of the World Federation of Hemophilia 2001;7(3):242-9.
2001: Keiji Nogami; Midori Shima; John C Giddings; Kazuya Hosokawa; M Nagata; Seiki Kamisue; Hiroshi Suzuki; Masaru Shibata; Evgueni L Saenko; Ichiro Tanaka; Akira Yoshioka
Circulating factor VIII immune complexes in patients with type 2 acquired hemophilia A and protection from activated protein C-mediated proteolysis.
Blood 2001;97(3):669-77.
2000: Masaru Shibata; Midori Shima; Shogo Morichika; John H McVey; Edward G D Tuddenham; Ichiro Tanaka; Hiroshi Suzuki; Keiji Nogami; Yoko Minamoto; Takaaki Hato; Evgueni L Saenko; Dorothea Scandella; Akira Yoshioka
An alloantibody recognizing the FVIII A1 domain in a patient with CRM reduced haemophilia A due to deletion of a large portion of the A1 domain DNA sequence.
Thrombosis and haemostasis 2000;84(3):442-8.
2000: Keiji Nogami; Midori Shima; Kazuya Hosokawa; M Nagata; T Koide; Evgueni L Saenko; Ichiro Tanaka; Masaru Shibata; Akira Yoshioka
Factor VIII C2 domain contains the thrombin-binding site responsible for thrombin-catalyzed cleavage at Arg1689.
The Journal of biological chemistry 2000;275(33):25774-80.
1999: Keiji Nogami; Midori Shima; Kazuya Hosokawa; T Suzuki; T Koide; Evgueni L Saenko; Dorothea Scandella; Masaru Shibata; Seiki Kamisue; Ichiro Tanaka; Akira Yoshioka
Role of factor VIII C2 domain in factor VIII binding to factor Xa.
The Journal of biological chemistry 1999;274(43):31000-7.
1999: Keiji Nogami; Midori Shima; H Nakai; Ichiro Tanaka; Hiroshi Suzuki; Shogo Morichika; Masaru Shibata; Evgueni L Saenko; Dorothea Scandella; John C Giddings; Akira Yoshioka
Identification of a factor VIII peptide, residues 2315-2330, which neutralizes human factor VIII C2 inhibitor alloantibodies: requirement of Cys2326 and Glu2327 for maximum effect.
British journal of haematology 1999;107(1):196-203.
1999: Masaru Shibata; Midori Shima; Yoshihiro Fujimura; Y Takahashi; H Nakai; Yoshihiko Sakurai; M Asatani; A Nomura; H Take; John C Giddings; Akira Yoshioka
Identification of the binding site for an alloantibody to von Willebrand factor which inhibits binding to glycoprotein Ib within the amino-terminal region flanking the A1 domain.
Thrombosis and haemostasis 1999;81(5):793-8.
1999: H Matsui; M Sugimoto; S Tsuji; Midori Shima; John C Giddings; Akira Yoshioka
Transient hypoplastic anemia caused by primary human parvovirus B19 infection in a previously untreated patient with hemophilia transfused with a plasma-derived, monoclonal antibody-purified factor VIII concentrate.
Journal of pediatric hematology/oncology 1999;21(1):74-6.
1998: Hiroshi Suzuki; Midori Shima; Seiki Kamisue; H Nakai; Keiji Nogami; Masaru Shibata; Shogo Morichika; Ichiro Tanaka; John C Giddings; Akira Yoshioka
The role of platelet von Willebrand factor in the binding of factor VIII to activated platelets.
Thrombosis research 1998;90(5):207-14.
1998: Midori Shima
[Variant type von Willebrand disease with defective binding to factor VIII].
Ryōikibetsu shōkōgun shirīzu 1998;(21 Pt 2):430-3.
1997: M Shibata; Y Imanaka; Midori Shima; Akira Yoshioka
[A case of postencephalitic intractable partial epilepsy with multiple brain lesions demonstrated by MRI].
No to hattatsu. Brain and development 1997;29(6):481-7.
1997: Midori Shima; I Tanaka; Y Sawamoto; H Kanehiro; N Matsuo; A Nishimura; John C Giddings; Akira Yoshioka
Successful treatment of two brothers with congenital afibrinogenemia for splenic rupture using heat- and solvent detergent-treated fibrinogen concentrates.
Journal of pediatric hematology/oncology 1997;19(5):462-5.
1997: Shogo Morichika; Midori Shima; Seiki Kamisue; Ichiro Tanaka; Y Imanaka; Hiroshi Suzuki; H Shibata; S Pemberton; K Gale; John H McVey; Edward G D Tuddenham; Akira Yoshioka
Factor VIII gene analysis in Japanese CRM-positive and CRM-reduced haemophilia A patients by single-strand conformation polymorphism.
British journal of haematology 1997;98(4):901-6.
1997: Hiroshi Suzuki; Midori Shima; M Arai; K Kagawa; K Fukutake; Seiki Kamisue; H Nakai; Shogo Morichika; Ichiro Tanaka; M Inoue; K Gale; Edward G D Tuddenham; Akira Yoshioka
Factor VIII Ise (R2159C) in a patient with mild hemophilia A, an abnormal factor VIII with retention of function but modification of C2 epitopes.
Thrombosis and haemostasis 1997;77(5):862-7.
1997: Y Sawamoto; Midori Shima; Ichiro Tanaka; H Nakai; Seiki Kamisue; Dorothea Scandella; Akira Yoshioka
Anti-factor VIII inhibitor alloantibodies recognizing the A2 domain in the human factor VIII heavy chain poorly bind to porcine factor VIII.
International journal of hematology 1997;65(2):151-8.